
Chih-ming Weng
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Aspartame and asthma: immunomodulatory effects on airway inflammation.
Journal: Respiratory research
Published: October 30, 2025
Fibrocytes as Key Mediators of Type 2 Inflammation in Asian Chronic Rhinosinusitis With Nasal Polyps.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: October 23, 2025
FNDC5/Irisin Attenuates TGF-β-induced Fibroblast Differentiation Via AMPK/Nrf2 Signaling and Mitochondrial Stabilization in Subepithelial Fibrosis.
Journal: Inflammation
Published: September 10, 2025
IL-33/ST2 axis mediates diesel exhaust particles-induced mast cell activation.
Journal: Molecular medicine (Cambridge, Mass.)
Published: August 14, 2024
Personalized serum proteome profiles of COVID-19-associated acute respiratory distress syndrome in response to mesenchymal stem cell therapy.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: March 11, 2024
Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma.
Journal: Respirology (Carlton, Vic.)
Published: August 26, 2023
Airway epithelium IgE-FcεRI cross-link induces epithelial barrier disruption in severe T2-high asthma.
Journal: Mucosal immunology
Published: March 16, 2023
Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by disrupting HDAC2/Sin3A/MeCP2 corepressor complex.
Journal: Journal of biomedical science
Published: November 23, 2022
Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: February 15, 2022
pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
Journal: Frontiers in immunology
Published: February 08, 2022
Last Updated: 09/26/2026